Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

FGEN

FibroGen (FGEN)

FibroGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FGEN
DateTimeSourceHeadlineSymbolCompany
17/09/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
14/09/202406:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
10/09/202410:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
10/09/202410:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
10/09/202410:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
07/09/202406:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
04/09/202406:05GlobeNewswire Inc.FibroGen to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:FGENFibroGen Inc
08/08/202407:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FGENFibroGen Inc
08/08/202407:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
07/08/202406:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FGENFibroGen Inc
07/08/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
07/08/202406:05GlobeNewswire Inc.FibroGen Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:FGENFibroGen Inc
06/08/202406:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
31/07/202406:07GlobeNewswire Inc.FibroGen to Report Second Quarter 2024 Financial ResultsNASDAQ:FGENFibroGen Inc
31/07/202406:05GlobeNewswire Inc.FibroGen Announces Topline Results from Two Late-Stage Pamrevlumab Pancreatic Cancer Studies and Provides Corporate UpdateNASDAQ:FGENFibroGen Inc
11/07/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FGENFibroGen Inc
09/07/202406:32Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:FGENFibroGen Inc
18/06/202422:00GlobeNewswire Inc.FibroGen to Host Part II of Virtual KOL Investor Event Series to Review FG-3246 Development Program in Metastatic Castration-Resistant Prostate Cancer on June 26, 2024NASDAQ:FGENFibroGen Inc
14/06/202406:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
11/06/202408:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
08/06/202409:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
08/06/202409:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
08/06/202406:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
07/06/202410:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
07/06/202410:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
07/06/202410:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
07/06/202410:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
07/06/202410:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
07/06/202410:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
07/06/202410:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
 Showing the most relevant articles for your search:NASDAQ:FGEN